metricas
covid
Clinics Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellula...
Journal Information

Statistics

Follow this link to access the full text of the article

BASIC RESEARCH
Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells
Yafei ZhangI,II, Bicheng ZhangI, Anran ZhangII, Yong ZhaoI, Jie ZhaoI, Jian LiuI, Jianfei GaoI, Dianchun FangII, Zhiguo RaoI,
Corresponding author
raozhiguo2012@163.com

Tel.: 86 27 68878464
I Wuhan General Hospital of Guangzhou Command, Department of Oncology, People’s Liberation Army, Wuhan, China.
II Third Military Medical University, Southwest Hospital, Department of Gastroenterology, Chongqing, China.
Read
2034
Times
was read the article
667
Total PDF
1367
Total HTML
Share statistics
Article information
ISSN: 18075932
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 24 20 44
2025 11 80 91 171
2025 10 60 60 120
2025 9 60 47 107
2025 8 49 49 98
2025 7 87 20 107
2025 6 46 5 51
2025 5 42 13 55
2025 4 50 2 52
2025 3 30 10 40
2025 2 24 4 28
2025 1 38 10 48
2024 12 25 4 29
2024 11 30 20 50
2024 10 24 20 44
2024 9 23 16 39
2024 8 42 27 69
2024 7 27 22 49
2024 6 21 15 36
2024 5 36 12 48
2024 4 26 7 33
2024 3 36 12 48
2024 2 43 14 57
2024 1 24 10 34
2023 12 29 20 49
2023 11 32 21 53
2023 10 27 31 58
2023 9 26 23 49
2023 8 34 11 45
2023 7 34 16 50
2023 6 35 13 48
2023 5 46 0 46
2023 4 48 2 50
2023 3 50 2 52
2023 2 26 8 34
2023 1 9 5 14
2022 12 24 5 29
Show all

Follow this link to access the full text of the article